Back to Journals » OncoTargets and Therapy » Volume 6

Review

Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC

      
Total article views   HTML views PDF downloads Totals
19,152 Dovepress* 11,928+ 3,116 15,044
PubMed Central* 7,224 2,006 9,230
Totals 19,152 5,122 24,274
*Since 5 March 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar